Results 191 to 200 of about 681,060 (251)

Nanostructured Deep Eutectic Systems in Healthcare: From Bioactive Solvents to Intelligent Biointerfaces, Wearables, and AI‐Driven Design

Advanced NanoBiomed Research, EarlyView.
Beyond the green solvent paradigm, this review redefines Deep Eutectic Systems (DES) as programmable supramolecular nanoassemblies. We survey their biomedical convergence: stabilizing thermolabile mRNA to enable cold chain‐free logistics, reshaping transdermal microneedle delivery, enabling long‐term wearables via eutectogels, and utilizing Generative ...
Jeesu Moon, Min Seo Kim, Jae‐Seung Lee
wiley   +1 more source

Spectroscopic and In Silico Determination of the Structural and Antioxidant Properties of Essential Oils From Lavandula Species Cultivated in the Silivri Region of Istanbul

Journal of the American Oil Chemists' Society, EarlyView.
ABSTRACT Plants are important sources of bioactive compounds that contribute to nutrition, health maintenance, and disease prevention. In this study, the chemical composition and antioxidant potential of essential oils obtained from Lavandula angustifolia “Sevtopolis” and Lavandula × intermedia cultivated in the Silivri region of Istanbul were ...
Bilge Bicak, Beray Kizilkaya, Serda Kecel Gunduz, Aliye Demet Demirag, Sabriye Percin Ozkorucuklu   +4 more
wiley   +1 more source

Treatment-resistant depression.

The Western journal of medicine, 1992
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

New England Journal of Medicine, 2023
BACKGROUND In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low and the percentage with relapse is high ...
Oliveira-Maia Aj, Andreas Reif, Tetsuro Itô   +2 more
exaly   +2 more sources

Esketamine for treatment resistant depression

Expert Review of Neurotherapeutics, 2019
Introduction: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants.
Serdar Dursun, Pratap Chokka, Michael L Demas   +2 more
exaly   +5 more sources

Insomnia and treatment-resistant depression

2023
Depression and sleep disturbance are related closely with bidirectional relationship. The heterogenic diagnostic criteria of major depressive disorder composed by the myriad combination of symptoms including sleep disturbance. Insomnia is an identifiable risk factor for depression and the treatment of insomnia might be able to prevent subsequent major ...
Wei-Chen, Lin, John Weyl, Winkelman
openaire   +2 more sources

Tinnitus and treatment-resistant depression

2023
Tinnitus, a frequent disorder, is the conscious perception of a sound in the absence of a corresponding external acoustic sound source in the sense of a phantom sound. Although the majority of people who perceive a tinnitus sound can cope with it and are only minimaly impaired in their quality of lfe, 2-3% of the population perceive tinnitus as a major
Berthold, Langguth, An-Suey, Shiao, Jen-Tsung, Lai, Tai-Shih, Chi, Franziska, Weber, Martin, Schecklmann, Lieber Po-Hung, Li   +6 more
openaire   +2 more sources

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.

American Journal of Psychiatry, 2023
One in three adults with major depressive disorder (MDD) do not experience clinically significant improvement after multiple sequential courses of antidepressants and have treatment-resistant depression (TRD).
M. Jha, S. Mathew
semanticscholar   +1 more source

Overview of treatment-resistant depression.

Progress in Brain Research, 2023
Patients with major depressive disorder (MDD) often exhibit an inadequate treatment response or failure to achieve remission following treatment with antidepressant drugs. Treatment-resistant depression (TRD) is proposed to identify this clinical scenario.
Cheng-Ta Li
semanticscholar   +3 more sources

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis.

Journal of Psychiatric Research, 2022
Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The acute efficacy of ketamine in TRD has been demonstrated in replicated randomised-controlled trials (RCTs), but the generalizability of RCT data to real-world practice
Yazen Alnefeesi, D. Chen-Li, Ella Krane, Muhammad Youshay Jawad, Nelson B Rodrigues, Felicia Ceban, Joshua D. Di Vincenzo, Shakila Meshkat, R. Ho, H. Gill, K. Teopiz, Bing Cao, Yena Lee, R. McIntyre, J. Rosenblat   +14 more
semanticscholar   +1 more source